BMO Capital analyst Evan Seigerman reiterated an Underperform rating and $52.00 price target on Incyte (NASDAQ: INCY).The analyst commented, "Incyte ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE